AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
1-Year Est. Return 6.63%
This Quarter Est. Return
1 Year Est. Return
+6.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$820M
AUM Growth
-$259M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
14
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$13.9M
2
+$5.2M
3
+$2.11M
4
SPRO icon
Spero Therapeutics
SPRO
+$101K
5
DYN icon
Dyne Therapeutics
DYN
+$18.4K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$197M 24.03%
4,896,462
2
$189M 23.05%
8,019,354
-782
3
$159M 19.41%
2,509,456
4
$107M 13.06%
10,402,286
-505,573
5
$81.5M 9.94%
6,430,257
6
$43.3M 5.28%
1,137,149
7
$9.92M 1.21%
5,836,874
8
$8.78M 1.07%
827,948
9
$8.23M 1%
418,182
10
$7.2M 0.88%
2,092,106
11
$4.77M 0.58%
51,407
12
$3.62M 0.44%
78,447
-300,000
13
$314K 0.04%
305,255
-97,630
14
– –
-76,979